John L. Flavin
CIK: 0001126556
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PYXS
Pyxis Oncology, Inc.
Director
Discretionary Trading P&L
Holdings
About FLAVIN JOHN L
FLAVIN JOHN L (SEC CIK 0001126556) files insider reports with the SEC as Director of Pyxis Oncology, Inc. (PYXS).
Signal8 holds 2 ownership filings by FLAVIN JOHN L, all Form 4s, filed between Apr 2, 2025 and Mar 25, 2026. Those filings report 2 transactions, from Mar 31, 2025 to Mar 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on FLAVIN JOHN L's filings is in BOSTON, MA.
Recent filings by FLAVIN JOHN L
Other insiders filing for Pyxis Oncology, Inc. (PYXS)
- GordonMD Global Investments LP, 10% Owner
- Civik Thomas, CEO & Chairman of the Board
- Dupont Jakob, Director
- Wadhane Jitendra, Prin Fin & Acct Officer
- Metzger Michael A, Director
- Lewis-Hall Freda C, Director